Piccin Andrea, Cronin Marina, Brady Róisín, Sweeney Jackie, Marcheselli Luigi, Lawlor Emer
Irish Blood Transfusion Service, Dublin, Ireland.
Trinity College University, Dublin, Ireland.
Transfusion. 2015 Jun;55(6):1223-30. doi: 10.1111/trf.12965. Epub 2014 Dec 18.
Transfusion-associated circulatory overload (TACO) is an increasingly reported condition but symptoms and signs are still unrecognized. We present a review of the incidence and clinical features of TACO reported to the National Haemovigilance Office at the Irish Blood Transfusion Service.
Between 2000 and 2010, a total of 1071 cases of serious transfusion-related reactions were reported, of which 221 (21%) cases were TACO.
A total of 2,000,684 blood components were issued, with a TACO incidence of one in 9177. The TACO incidence per red blood cells, plasma, and platelet components issued was one in 8000, one in 16,000, and one in 57,884, respectively. The majority of cases (68%, n = 151) were elderly patients, while no sex difference was seen. Twenty-eight (13%) patients experienced severe morbidity; 31 (14%) deaths were reported, of which five (2%) were considered due to TACO and the other deaths considered due to and underlying conditions, which in most cases were cardiovascular (76%). An increased risk of mortality was found in patients on diuretics either before transfusion as part of their routine therapy or given as pretransfusion medication (odds ratio, 2.49; 95% confidence interval, 1.06-6.01). In 19 (21%) cases, TACO reaction was due to human error.
The strong association between TACO and human errors supports the role of hemovigilance and of adequate transfusion medicine teaching for preventing morbidity and mortality associated with TACO.
输血相关循环超负荷(TACO)是一种报告日益增多的病症,但症状和体征仍未得到充分认识。我们对爱尔兰输血服务中心国家血液警戒办公室报告的TACO的发病率和临床特征进行了综述。
2000年至2010年间,共报告了1071例严重的输血相关反应,其中221例(21%)为TACO。
共发放了2000684个血液成分,TACO发病率为1/9177。每发放的红细胞、血浆和血小板成分的TACO发病率分别为1/8000、1/16000和1/57884。大多数病例(68%,n = 151)为老年患者,未观察到性别差异。28例(13%)患者出现严重发病情况;报告了31例(14%)死亡病例,其中5例(2%)被认为是由TACO所致,其他死亡病例被认为是由基础疾病所致,在大多数情况下为心血管疾病(76%)。发现接受利尿剂治疗的患者,无论是作为常规治疗的一部分在输血前使用,还是作为输血前用药,其死亡风险都会增加(优势比,2.49;95%置信区间,1.06 - 6.01)。在19例(21%)病例中,TACO反应是人为失误所致。
TACO与人为失误之间的密切关联支持了血液警戒以及充分的输血医学教学在预防与TACO相关的发病和死亡方面的作用。